| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | CEO And President | Director
2 companies
Passeri Daniel R is a Director at CURIS INC with holdings across 2 companies. Recent SEC Form 4 filings include 7 buys and 6 sells.
Estimated insider holdings value: $5.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | CUE Cue Biopharma, Inc. | Chief Executive Officer | Buy | 30,000 | $1.03 | $30,900.00 | +22.3% | -6.9% | -59.8% | |
| Aug 14, 2023 | CUE Cue Biopharma, Inc. | Chief Executive Officer | Buy | 3,000 | $2.86 | $8,580.00 | +2.3% | -22.1% | -79.3% | |
| Sep 24, 2021 | CUE Cue Biopharma, Inc. | Chief Executive Officer | Buy | 3,400 | $14.72 | $50,051.40 | +6.5% | -14.2% | -81.7% | |
| Jun 21, 2019 | CUE Cue Biopharma, Inc. | CEO And President | Buy | 1,377 | $7.26 | $9,997.02 | +2.7% | - | - | |
| Jun 6, 2019 | CUE Cue Biopharma, Inc. | CEO And President | Buy | 3,000 | $6.90 | $20,700.00 | +6.3% | - | - | |
| Aug 16, 2018 | CUE Cue Biopharma, Inc. | CEO And President | Buy | 6,000 | $8.09 | $48,510.00 | +14.4% | - | - | |
| Jun 29, 2018 | CUE Cue Biopharma, Inc. | CEO And President | Buy | 1,600 | $11.97 | $19,152.00 | +4.0% | - | - | |
| Dec 30, 2015 | CRIS Curis Inc | Director | Sale+OE | 25,600 | $2.97 | $75,936.00 | -6.0% | - | - | |
| Dec 28, 2015 | CRIS Curis Inc | Director | Sale+OE | 13,600 | $2.85 | $38,780.00 | -3.3% | - | - | |
| Dec 23, 2015 | CRIS Curis Inc | Director | Sale+OE | 48,900 | $2.78 | $136,110.00 | -10.9% | - | - |